Rockefeller University researchers discover hundreds of new bacteria and two potential antibiotics in soil using DNA sequencing
By
PaulHoule
Pure flour-power. Hearty enough to carry you through lunch.
Summary
Researchers at Rockefeller University have developed a method to access the genetic material of soil bacteria that cannot be cultured in a lab, uncovering hundreds of new bacteria and two potential antibiotics. This approach taps into a vast hidden reservoir of microbial compounds that could help address the growing crisis of antibiotic resistance and the drying pipeline of new drugs.
Key quotes
· 3 pulledMost bacteria cannot be cultured in the lab—and that's been bad news for medicine.
Many of our frontline antibiotics originated from microbes, yet as antibiotic resistance spreads and drug pipelines run dry, the soil beneath our feet has a vast hidden reservoir of untapped lifesaving compounds.
Now, researchers have developed a way to access this microbial gold
You might also wanna read
Google's Debug program seeks EPA approval to release 64 million modified mosquitoes in California and Florida
Google's Debug program plans to release up to 64 million genetically modified "good" mosquitoes in California and Florida over two years to
bit.ly·1h ago
Researchers develop phage-based preventive treatment for newborn meningitis caused by E. coli K1
Researchers from the Biozentrum, University of Basel, and ETH Zurich have developed a novel preventive treatment for newborn meningitis caus
biozentrum.unibas.ch·2h ago
Daily pill daraxonrasib doubles survival for metastatic pancreatic cancer patients with KRAS mutation
A new daily pill called daraxonrasib has been shown to double survival time for metastatic pancreatic cancer patients with a KRAS mutation.
bbc.co.uk·5h ago
Exploring the science behind quantum effects in healthcare: separating research from pseudoscience
The article explores the intersection of quantum physics and healthcare, distinguishing between pseudoscientific "quantum therapies" and leg
newscientist.com·6h ago
Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
chicagotribune.com·7h agoExperimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
chicagotribune.com·7h ago